ACADNasdaq United States
Market cap
$5.033 B
$29.21 +2.67%
Close of 7 Aug 2026
Revenue
$1.07B
#1492 by revenue
Earnings
$391.0M
#727 by earnings
Shares outstanding
172,305,518
Latest filing cover page
P/E ratio
12.9
Cap ÷ net income
Where these numbers come from
Share counts and financials for Acadia Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.